Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03412656 · ClinicalTrials.gov registry record · NA
Assessing Force Feedback With the SoftHand Pro
A NA study of Amputation, Traumatic and Limb Defect, sponsored by Kristin Zhao, PhD.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03412656: Completed NA study of Amputation, Traumatic and Limb Defect, sponsored by Kristin Zhao, PhD.
NCT03412656 is a NA study of Amputation, Traumatic and Limb Defect that has completed, run by Kristin Zhao, PhD. The registered enrollment target is 27 participants, below the 51-participant average among 11 other Amputation, Traumatic trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03412656, a NA study of Amputation, Traumatic and Limb Defect, has completed, sponsored by Kristin Zhao, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The trial is designed to test the effectiveness of a force-feedback cuff in combination with a myoelectric prosthesis in conveying information on grasp strength to the user, as well as the user's preference regarding the feature.
Primary Outcome
Assessments will measure the extent to which the CUFF device conveys haptic force feedback, when used in combination with the Soft Hand Pro.
Conditions Studied
Interventions
- DEVICE SoftHand Pro with CUFF force feedback device
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2019-06-14 |
| Phase | NA |
What the finished NCT03412656 record still lists
NCT03412656 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 51-participant average among 11 other Amputation, Traumatic trials with a reported enrollment target (47% lower).
The record links to 2 conditions, with Amputation, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which SoftHand Pro with CUFF force feedback device is the first listed.
NCT03412656 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03412656 about?
NCT03412656 is a clinical study titled "Assessing Force Feedback With the SoftHand Pro". The trial is designed to test the effectiveness of a force-feedback cuff in combination with a myoelectric prosthesis in conveying information on grasp strength to the user, as well as the user's preference regarding the feature.
What is the current status of trial NCT03412656?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2017-10-17. Estimated completion is 2019-06-14.
What conditions does trial NCT03412656 study?
This clinical trial studies the following conditions: Amputation, Traumatic, Limb Defect.
What interventions are being tested in trial NCT03412656?
The interventions under investigation include: SoftHand Pro with CUFF force feedback device (DEVICE).
Who is sponsoring clinical trial NCT03412656?
This trial is sponsored by Kristin Zhao, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03412656 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03412656's enrollment target sits among peer trials
27 9th of 11 higher than 3 of 11 other Amputation, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait
RECRUITING · NA
-
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
RECRUITING · NA
-
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
ACTIVE NOT RECRUITING · NA
-
GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices
ACTIVE NOT RECRUITING · NA
-
SoftHand Comparison Study
ACTIVE NOT RECRUITING · NA
-
Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI